Geode Capital Management’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.7M | Buy |
1,335,437
+56,203
| +4% | +$1.46M | ﹤0.01% | 1629 |
|
|
2025
Q1 | $31.3M | Buy |
1,279,234
+122,564
| +11% | +$3M | ﹤0.01% | 1644 |
|
|
2024
Q4 | $33.2M | Buy |
1,156,670
+78,143
| +7% | +$2.24M | ﹤0.01% | 1678 |
|
|
2024
Q3 | $40.7M | Buy |
1,078,527
+528,749
| +96% | +$20M | ﹤0.01% | 1557 |
|
|
2024
Q2 | $17.4M | Buy |
549,778
+45,562
| +9% | +$1.44M | ﹤0.01% | 2011 |
|
|
2024
Q1 | $22.1M | Buy |
+504,216
| New | +$22.1M | ﹤0.01% | 1870 |
|